Innovation-driven medical device and software solutions company Breg, Inc announced on Wednesday that it has named Dave Mowry as its new chief executive officer and Matt Simons as its new Chief Financial Officer.
Mowry, who is to continue to serve as the chairman of the board, said, 'After an evaluation of the business and market, during my time serving as interim CEO, my optimism about Breg's vast opportunities has only grown. We are excited about becoming the leader in an under-appreciated market segment. We are already building momentum within the business as we shift the focus toward true innovation and category and channel expansion. We have a long road ahead, but I have great confidence in the team as we build discipline and consistency to achieving our financial objectives both in the short and long term.'
Simons is an experienced senior financial executive with more than 25 years of strategic financial leadership experience. In the new role, Simons is to head the company's finance initiatives, business development efforts and accounting and finance teams.
Mindray unveils BeneVision V Series at Euroanaesthesia 2025, advancing precision monitoring
Unicon Pharma and VRR Life Sciences partner support digital transformation in life sciences
Median Technologies submits 510(k) application for eyonis LCS lung cancer screening software
Tristel secures FDA clearance for Ophthalmic Disinfectant Tristel OPH
LakeShore Biopharma launches novel packaging solution for YSJA rabies vaccine (Vero cell)
Coologics' seed funding round raises over USD3m
DDL opens new GMP laboratory for drug-device combination product testing
Abbott receives CE Mark for Volt Pulsed Field Ablation System to treat atrial fibrillation
Vast Therapeutics' ALX1 drug candidate granted QIDP designation by US FDA
Qlife secures UK approval to initiate clinical trial for Egoo Phe System